Abstract
Pericytes have long been known to contribute indirectly to tumour growth by regulating angiogenesis. Thus, remodelling tumour blood vessels to maintain blood supply is critical for continued tumour growth. A role for pericytes in restricting leakage of tumour cells through blood vessels has also become evident given that adequate pericyte coverage of these blood vessels is critical for maintaining vascular permeability. Interestingly, the relocation of pericytes from blood vessels to the tumour microenvironment results in the emergence of different properties in these cells that actively promote tumour growth and metastasis—functions not associated with their well-studied role in vascular stability and permeability. These form the focus of this review.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Bergers, G., et al. (2003). Benefits of targeting both pericytes and endothelial cells in the tumor vasculature with kinase inhibitors. The Journal of Clinical Investigation, 111(9), 1287–1295.
Birbrair, A., & Frenette, P. S. (2016). Niche heterogeneity in the bone marrow. Annals of the New York Academy of Sciences, 1370(1), 82–96.
Calon, A., et al. (2015). Stromal gene expression defines poor-prognosis subtypes in colorectal cancer. Nature Genetics, 47(4), 320–329.
Caplan, A. I. (2008). All MSCs are pericytes? Cell Stem Cell, 3(3), 229–230.
Cirri, P., & Chiarugi, P. (2011). Cancer associated fibroblasts: the dark side of the coin. American Journal of Cancer Research, 1(4), 482–497.
Cooke, V. G., et al. (2012). Pericyte depletion results in hypoxia-associated epithelial-to-mesenchymal transition and metastasis mediated by met signaling pathway. Cancer Cell, 21(1), 66–81.
Crisan, M., et al. (2008). A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell, 3(3), 301–313.
Cunha, G. R., et al. (2003). Role of the stromal microenvironment in carcinogenesis of the prostate. International Journal of Cancer, 107(1), 1–10.
Druker, B. J. (2002). STI571 (Gleevec) as a paradigm for cancer therapy. Trends in Molecular Medicine, 8(4 Suppl), S14–S18.
Dulauroy, S., et al. (2012). Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury. Nature Medicine, 18(8), 1262–1270.
Erber, R., et al. (2004). Combined inhibition of VEGF and PDGF signaling enforces tumor vessel regression by interfering with pericyte-mediated endothelial cell survival mechanisms. The FASEB Journal, 18(2), 338–340.
Finak, G., et al. (2008). Stromal gene expression predicts clinical outcome in breast cancer. Nature Medicine, 14(5), 518–527.
Frame, M. C., & Serrels, A. (2015). FAK to the rescue: activated stroma promotes a “safe haven” for BRAF-mutant melanoma cells by inducing FAK signaling. Cancer Cell, 27(4), 429–431.
Fujita, H., et al. (2010). alpha-Smooth muscle actin expressing stroma promotes an aggressive tumor biology in pancreatic ductal adenocarcinoma. Pancreas, 39, 1254–1262.
Greenhalgh, S. N., Conroy, K. P., & Henderson, N. C. (2015). Healing scars: targeting pericytes to treat fibrosis. QJM: An International Journal of Medicine, 108(1), 3–7.
Hamzah, J., et al. (2008). Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature, 453(7193), 410–414.
Hosaka, K., et al. (2013). Tumour PDGF-BB expression levels determine dual effects of anti-PDGF drugs on vascular remodelling and metastasis. Nature Communications, 4, 2129.
Huang, J., et al. (2018). Adipocyte p62/SQSTM1 suppresses tumorigenesis through opposite regulations of metabolism in adipose tissue and tumor. Cancer Cell, 33(4), 770–784 e6.
Hung, S. C., et al. (2005). Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clinical Cancer Research, 11(21), 7749–7756.
Kalluri, R., & Zeisberg, M. (2006). Fibroblasts in cancer. Nature Reviews. Cancer, 6(5), 392–401.
Karnoub, A. E., et al. (2007). Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature, 449(7162), 557–563.
Kawase, E., et al. (2004). Gbb/Bmp signaling is essential for maintaining germline stem cells and for repressing bam transcription in the Drosophila testis. Development, 131(6), 1365–1375.
Kramann, R., & Humphreys, B. D. (2014). Kidney pericytes: Roles in regeneration and fibrosis. Seminars in Nephrology, 34(4), 374–383.
Kuhnert, F., et al. (2008). Soluble receptor-mediated selective inhibition of VEGFR and PDGFRbeta signaling during physiologic and tumor angiogenesis. Proceedings of the National Academy of Sciences of the United States of America, 105(29), 10185–10190.
Lin, S.-L., et al. (2008). Pericytes and perivascular fibroblasts are the primary source of collagen-producing cells in obstructive fibrosis of the kidney. The American Journal of Pathology, 173(6), 1617–1627.
Lindblom, P., et al. (2003). Endothelial PDGF-B retention is required for proper investment of pericytes in the microvessel wall. Genes & Development, 17(15), 1835–1840.
Maciag, P. C., et al. (2008). Cancer immunotherapy targeting the high molecular weight melanoma-associated antigen protein results in a broad antitumor response and reduction of pericytes in the tumor vasculature. Cancer Research, 68(19), 8066–8075.
McLean, K., et al. (2011). Human ovarian carcinoma-associated mesenchymal stem cells regulate cancer stem cells and tumorigenesis via altered BMP production. The Journal of Clinical Investigation, 121(8), 3206–3219.
Mederacke, I., et al. (2013). Fate-tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its etiology. Nature Communications, 4, 2823–2823.
Mills, S. J., et al. (2015). Effects of human pericytes in a murine excision model of wound healing. Experimental Dermatology, 24(11), 881–882.
Mishra, P. J., et al. (2008). Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Research, 68(11), 4331–4339.
Morikawa, S., et al. (2002). Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors. The American Journal of Pathology, 160(3), 985–1000.
Morrison, S. J., & Scadden, D. T. (2014). The bone marrow niche for haematopoietic stem cells. Nature, 505(7483), 327–334.
Navarro, R., et al. (2016). Immune regulation by pericytes: Modulating innate and adaptive immunity. Frontiers in Immunology, 7, 480.
Ning, X., et al. (2018). Exosomes released by gastric cancer cells induce transition of pericytes into cancer-associated fibroblasts. Medical Science Monitor, 24, 2350–2359.
Nisancioglu, M. H., Betsholtz, C., & Genove, G. (2010). The absence of pericytes does not increase the sensitivity of tumor vasculature to vascular endothelial growth factor-A blockade. Cancer Research, 70(12), 5109–5115.
Olumi, A. F., et al. (1999). Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium. Cancer Research, 59(19), 5002–5011.
Paiva, A. E., et al. (2018). Pericytes in the premetastatic niche. Cancer Research, 78(11), 2779–2786.
Paquet-Fifield, S., et al. (2009). A role for pericytes as microenvironmental regulators of human skin tissue regeneration. The Journal of Clinical Investigation, 119(9), 2795–2806.
Pietras, K., & Ostman, A. (2010). Hallmarks of cancer: interactions with the tumor stroma. Experimental Cell Research, 316(8), 1324–1331.
Quante, M., et al. (2011). Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell, 19(2), 257–272.
Ribeiro, A. L., & Okamoto, O. K. (2015). Combined effects of pericytes in the tumor microenvironment. Stem Cells International, 2015, 868475.
Ruoslahti, E. (2002). Specialization of tumour vasculature. Nature Reviews. Cancer, 2(2), 83–90.
Sa da Bandeira, D., Casamitjana, J., & Crisan, M. (2017). Pericytes, integral components of adult hematopoietic stem cell niches. Pharmacology & Therapeutics, 171, 104–113.
Sacchetti, B., et al. (2007). Self-renewing osteoprogenitors in bone marrow sinusoids can organize a hematopoietic microenvironment. Cell, 131(2), 324–336.
Scharpfenecker, M., et al. (2005). The Tie-2 ligand angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. Journal of Cell Science, 118(Pt 4), 771–780.
Sena, I. F. G., et al. (2018). Glioblastoma-activated pericytes support tumor growth via immunosuppression. Cancer Medicine, 7(4), 1232–1239.
Sennino, B., et al. (2007). Sequential loss of tumor vessel pericytes and endothelial cells after inhibition of platelet-derived growth factor B by selective aptamer AX102. Cancer Research, 67(15), 7358–7367.
Shi, Y., et al. (2018). Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nature Reviews Nephrology, 14, 493–507.
Sinha, D., et al. (2016). Pericytes promote malignant ovarian cancer progression in mice and predict poor prognosis in serous ovarian cancer patients. Clinical Cancer Research, 22(7), 1813–1824.
Song, X., et al. (2004). Bmp signals from niche cells directly repress transcription of a differentiation-promoting gene, bag of marbles, in germline stem cells in the Drosophila ovary. Development, 131(6), 1353–1364.
Stapor, P. C., et al. (2014). Pericyte dynamics during angiogenesis: new insights from new identities. Journal of Vascular Research, 51(3), 163–174.
Studeny, M., et al. (2002). Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Research, 62(13), 3603–3608.
Tothill, R. W., et al. (2008). Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome. Clinical Cancer Research, 14(16), 5198–5208.
Tsujino, T., et al. (2007). Stromal myofibroblasts predict disease recurrence for colorectal cancer. Clinical Cancer Research, 13(7), 2082–2090.
Vanlandewijck, M., et al. (2018). A molecular atlas of cell types and zonation in the brain vasculature. Nature, 554(7693), 475–480.
Viski, C., et al. (2016). Endosialin-expressing pericytes promote metastatic dissemination. Cancer Research, 76(18), 5313–5325.
Xian, X., et al. (2006). Pericytes limit tumor cell metastasis. The Journal of Clinical Investigation, 116(3), 642–651.
Zhuang, L., Lawlor, K. T., Schlueter, H., Pieterse, Z., Yu, Y., & Kaur, P. (2018). Pericytes promote skin regeneration by inducing epidermal cell polarity and planar cell divisions. Life Science Alliance, 1(4), e201700009.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Pieterse, Z., Sinha, D., Kaur, P. (2019). Pericytes in Metastasis. In: Birbrair, A. (eds) Pericyte Biology in Disease. Advances in Experimental Medicine and Biology, vol 1147. Springer, Cham. https://doi.org/10.1007/978-3-030-16908-4_5
Download citation
DOI: https://doi.org/10.1007/978-3-030-16908-4_5
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16907-7
Online ISBN: 978-3-030-16908-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)